Skip to main content
Contact us

Drug Substances CDMO Companies
Drug Substance Contract Manufacturing Services

Your Trusted Partners for Drug Substance Contract Manufacturing and Development

Showing 161 facilities
Liof Pharma S.L.U.
Spain

Liof Pharma S.L.U.

Liof Pharma S.L.U.

Socio CDMO de confianza para la fabricación aséptica y liofilización de productos biológicos y medicamentos inyectables.

MARKETS: EMA (EU), FDA (USA), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), INVIMA (Colombia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP)

USE: Human, Veterinary

BSL (Biological Safety Level): 1

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, BIOLOGICS, SERVICES, FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

THERAPEUTIC AREAS OF EXPERTISE (ATC): (L) Antineoplastic and immunomodulating agents

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

BATCH SIZE: Small

Sidefarma
Spain

Sidefarma

Sidefarma SA

Sidefarma es un CMO especializado en la fabricación de lotes peque os y medianos para compa ías farmacéuticas de todo el mundo, en mercados regulados y siguiend

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), DIGEMID (Peru), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), TGA (Australia)

REGION: Europe

COMPLIANCE: ISO, UAE Ministry of Health & Prevention, EMA (EU GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, SERVICES

USE: Human

SERVICES: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

BATCH SIZE: Small, Medium

CARBOGEN AMCIS | Saint-Beauzire
France

CARBOGEN AMCIS | Saint-Beauzire

CARBOGEN AMCIS

Desarrollo personalizado y producción aséptica automatizada de medicamentos líquidos y liofilizados

MARKETS: TGA (Australia), EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India)

THERAPEUTIC AREAS OF EXPERTISE (ATC): (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day)

COMPLIANCE: French Service-Public (CIR), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)

BATCH SIZE: Small, Medium, Large

CATEGORY / PRODUCT: BIOLOGICS, SERVICES, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

REGION: Europe

USE: Human

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

CARBOGEN AMCIS | Aarau
Switzerland

CARBOGEN AMCIS | Aarau

CARBOGEN AMCIS

Desarrollo y fabricación cGMP a mediana escala, incluida la cromatografía

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), CDSCO (India), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP)

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, OLIGONUCLEOTIDES, BIOLOGICS, SERVICES

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (L) Antineoplastic and immunomodulating agents

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

BATCH SIZE: Small, Medium

Adragos Pharma | Halden
Spain

Adragos Pharma | Halden

Adragos Pharma

Nos especializamos en la fabricación de bolsas intravenosas, ampollas y viales de plástico utilizando la tecnología Blow-Fill-Seal (BFS) y otras formas de dosif

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), TGA (Australia)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, NUTRACEUTICALS, OLIGONUCLEOTIDES, BIOLOGICS, SERVICES

USE: Human

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals, (L) Antineoplastic and immunomodulating agents, (V06) Nutrients, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Aenova Group - Location Kirchberg, Switzerland
Switzerland

Aenova Group - Location Kirchberg, Switzerland

Aenova

Centro de Competencia Cápsulas de gelatina blanda.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

MARKETS: EMA (EU), FDA (USA), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, Roszdravnadzor (Russia GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), World Health Organization (GMP / HACCP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, COSMETICS, NUTRACEUTICALS, SERVICES

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V06) Nutrients, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

MARKETS: EMA (EU), ANVISA (Brazil), CDSCO (India)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: ISO, ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, BIOLOGICS

USE: Human

BSL (Biological Safety Level): 2

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use, (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

BATCH SIZE: Small

Aenova Group - Location Carugate, Italy
Italy

Aenova Group - Location Carugate, Italy

Aenova

Centro de competencia Semisólidos y líquidos no estériles.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

MARKETS: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)

REGION: Europe

COMPLIANCE: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, COSMETICS

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals, (P) Antiparasitic products, insecticides and repellents

Aenova Group - Location Killorglin, Ireland
Ireland

Aenova Group - Location Killorglin, Ireland

Aenova

Centro de Competencia para secado por atomización (spray drying) y pellets de liberación modificada.

MARKETS: EMA (EU), PMDA (Japan), SFDA (Saudi Arabia), MFDS (South Korea)

REGION: Europe

COMPLIANCE: ISO, PMDA/MHLW (Japan GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, NUTRACEUTICALS, PARTICLE ENGINEERING

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Aenova Group - Location Gronau, Germany
Germany

Aenova Group - Location Gronau, Germany

Aenova

Centro de competencia para sólidos convencionales y servicios clínicos.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), ANVISA (Brazil), Russian Health Authorities, EDE (UAE)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), UAE Ministry of Health & Prevention, EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, BIOLOGICS, SERVICES

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (L) Antineoplastic and immunomodulating agents

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

Adragos Pharma | Livron
Spain

Adragos Pharma | Livron

Adragos Pharma

Fabricación de líquidos estériles y supositorios. Manejamos más de 100 moléculas y ofrecemos estudios de estabilidad, manejo de narcóticos y servicios de anális

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea), CDSCO (India), TGA (Australia)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, COSMETICS, SERVICES

USE: Human

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals

COMPLIANCE: EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

Aenova Group
Spain

Aenova Group

Aenova

Sede central - Ubicación Starnberg

MARKETS: EMA (EU), FDA (USA)

SERVICES: Logistics, Development services, Manufacturing services, Packaging

REGION: Europe

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, NUTRACEUTICALS, OLIGONUCLEOTIDES, SERVICES

USE: Human, Veterinary

THERAPEUTIC AREAS OF EXPERTISE (ATC): (P) Antiparasitic products, insecticides and repellents

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+81 more facilities

Create free account

The drug substance, whether a small molecule API or a complex biologic, is the foundation of every pharmaceutical product. Its quality, consistency, and regulatory readiness are critical to therapeutic success. That’s why pharma and biotech companies rely on experienced drug substance CDMO companies for scalable, compliant, and cost-effective manufacturing.

With specialized drug substance contract manufacturing services, these CDMOs support your active ingredient from early development through commercial production under strict GMP conditions.


How to Choose Drug Substance CDMO Companies

When selecting among drug substance CDMO companies, key evaluation points include:

  • Molecule type compatibility: Small molecules, peptides, oligonucleotides, biologics, or HPAPIs

  • Process development and optimization from preclinical to commercial scale

  • Facility and equipment readiness for chemical synthesis, fermentation, or cell culture

  • Containment capabilities for potent or hazardous materials

  • Analytical support for impurity profiling, stability, and release testing

  • Tech transfer and scale-up experience

  • Regulatory success with FDA, EMA, PMDA, and other health authorities

The right partner ensures your drug substance meets global quality standards from the start.


Key Services Offered by Drug Substance Contract Manufacturers

Comprehensive drug substance contract manufacturing services typically include:

  • Route scouting and synthetic pathway design for small molecules

  • Cell line development and fermentation for biologics

  • Upstream and downstream processing under GMP

  • Purification and crystallization optimization

  • Micronization or spray drying for final API form

  • Process validation and analytical method development

  • Batch record generation and GMP documentation

  • Regulatory support for IND, NDA, and global submissions

These services ensure your active ingredient is consistent, stable, and ready for formulation.


Advantages of Partnering with Drug Substance Contract Manufacturers

Working with top-tier drug substances CDMO companies offers clear benefits:

  • Reduced development risk through proven platforms and expertise

  • Speed to clinic or market with integrated R&D and GMP capabilities

  • High product quality supported by rigorous analytical testing

  • Global regulatory alignment with inspection-ready facilities

  • Custom scalability from milligram development to metric ton production

A trusted CDMO helps you advance your molecule from lab bench to large-scale supply efficiently and safely.


Drug Substance CDMO Companies

Some of the most trusted drug substance CDMO companies include:

  • Cambrex: Cambrex Longmont site focuses on the early-stage development and manufacturing of small-molecule pharmaceutical products within a fully integrated drug substance and drug product facility. [See CDMO profile]

  • ChemCon: German-based CDMO specializing in the synthesis of APIs and fine chemicals, with extensive expertise in transferring R&D processes into fully cGMP-compliant manufacturing. [See CDMO profile]

  • Pharmaron: Offers advanced small molecule development and manufacturing services for drug substances under strict regulatory standards. [See CDMO profile]

  • Laboratori Alchemia: Provides tailored chemical synthesis services for complex and novel compounds, including non-commercial and literature-unknown molecules. [See CDMO profile]

  • Viswa Laboratories: CDMO offering end-to-end services in APIs, intermediates, and specialty chemicals with strong expertise in CRAMS projects. [See CDMO profile]

  • Actylis: Partner for chemical process discovery, development, and cGMP manufacturing of small molecules and intermediates for pharmaceutical applications. [See CDMO profile]

  • Seacross Pharma: Global CMO/CDMO delivering customized API manufacturing solutions across three state-of-the-art production sites. [See CDMO profile]

  • VIVEbiotech: GMP-certified CDMO exclusively focused on the development and large-scale production of lentiviral vectors for gene and cell therapy. [See CDMO profile]

  • 53Biologics Production Plant: Biologics-focused CDMO offering end-to-end services from DNA to protein, covering preclinical development to full cGMP manufacturing. [See CDMO profile]

  • BDI Biotech: Operates as an outsourced R&D department specializing in microbial strain engineering, bioprocess optimization, and biomanufacturing scale-up. [See CDMO profile]

  • HISTOCELL S.L: Develops and manufactures advanced cell therapies based on iPSCs, MSCs, secretomes, and exosomes, alongside medical devices and dermocosmetic products. [See CDMO profile]

  • Cultiply: Provides development and optimization of production and purification processes for recombinant proteins, enzymes, plasmid DNA, and other bioproducts. [See CDMO profile]

  • Mabion: Comprehensive CDMO offering biotherapeutic development and GMP manufacturing, including monoclonal antibodies and recombinant protein-based products. [See CDMO profile]

  • Shilpa Biologicals: Full-service CDMO supporting process development from gene and cell line creation to GMP production, formulation, analytical testing, fill-finish, and packaging. [See CDMO profile]

  • Aenova Group: Competence center in sterile manufacturing and animal health products, offering development and production of injectable and aseptic formulations. [See CDMO profile]

  • HIPRA Biotech Services: Provides integrated solutions covering the entire value chain, from cell line development to commercial-scale biopharmaceutical manufacturing. [See CDMO profile]

  • CARBOGEN AMCIS: Expert in developing and manufacturing highly potent APIs at small scale, including specialized capabilities in chromatography and lyophilization. [See CDMO profile]

  • Sichuan Huiyu Pharmaceuticals Co.: Offers comprehensive services for the development and production of APIs and finished dosage forms under GMP conditions. [See CDMO profile]

  • MENADIONA S.L: Spanish-based CDMO focused on APIs, intermediates, and fine chemicals, with proven expertise in scaling R&D projects to cGMP manufacturing. [See CDMO profile]

  • Apeloa Pharmaceutical Co: Global provider of discovery, process development, and GMP manufacturing services for APIs, intermediates, and registered starting materials (RSMs). [See CDMO profile]

  • Lukas Heil-Betriebsstätte: Operates a high-performance GMP facility for the sterile and aseptic manufacturing of liquid pharmaceuticals, including glass ampoules. [See CDMO profile]

  • Rodon Biologics: Provides high-quality biopharmaceutical development and manufacturing services for third-party clients worldwide. [See CDMO profile]

  • Basic Pharma Manufacturing: Specializes in scaling up pharmaceutical production from laboratory to early clinical phases and market introduction. [See CDMO profile]

  • Adragos Pharma: Offers aseptic manufacturing of sterile lyophilized and liquid (bio)pharmaceutical products through state-of-the-art fill-and-finish technologies. [See CDMO profile]

  • CZ Vaccines: Commercial-scale vaccine manufacturing facility supporting investigational and marketed biological products. [See CDMO profile]

  • SINOWAY INDUSTRIAL CO: Provides one-stop CDMO solutions for APIs and key intermediates, from early-stage process development to large-scale manufacturing. [See CDMO profile]

  • Synfine: Reliable manufacturer and exporter of Active Pharmaceutical Ingredients (APIs) and intermediates, committed to global regulatory and quality standards. [See CDMO profile]

  • Kemwell Biopharma Pvt Ltd: Biologics-focused Contract Development and Manufacturing Organization (CDMO) providing integrated services to global biopharmaceutical companies. [See CDMO profile]

  • Cellex Cell Professionals: CGT-focused CDMO operating a cell manufacturing plant and a collection center for starting materials. [See CDMO profile]

  • Ascendia Pharmaceutical Solutions: GMP-certified CDMO specializing in advanced sterile and non-sterile pharmaceutical manufacturing, formulation development, and analytical testing. [See CDMO profile]

  • Green Phoenix Labs GmbH: Cell therapy company offering additional cleanroom capacity to support advanced therapy manufacturing. [See CDMO profile]

  • Hikal Ltd | Bangalore, India: cGMP process development, scale-up and manufacturing of small molecule APIs, NMEs and intermediates, from gram to kilogram and tonne scale, supporting projects from laboratory stage through commercial launch. [See CDMO profile]

  • Bilthoven Biologicals Drug Substance and Drug Product Facilities: Multi-product GMP facilities for Drug Substance and Drug Product manufacturing. [See CDMO profile]

  • Demo facility: Tissue therapy, Cell therapy and GTMP (Gene Therapy). [See CDMO profile]


Related Information


Let MAI CDMO Network Help You Find the Right CDMO Partner

At MAI CDMO Network, we specialize in matching pharma and biotech companies with the most qualified drug substance CDMO companies worldwide. Whether you need early-phase synthesis or global commercial API supply, our network of drug substance contract manufacturing partners delivers quality, compliance, and reliability.

 

Looking to accelerate your drug substance development or scale-up? Contact us today and find your perfect CDMO partner.